Vered Bisker-Leib
Chief Executive Officer at COMPASS THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-04-29
Network origin in Vered Bisker-Leib first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 74 | |
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Miscellaneous Commercial Services | 17 | |
| Subsidiary | Pharmaceuticals: Major | 10 | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA.
5
| Subsidiary | Biotechnology | 5 |
Cydan II, Inc.
 Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA.
2
| Extinct | Pharmaceuticals: Generic | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Vered Bisker-Leib via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Founder Consultant / Advisor Consultant / Advisor Consultant / Advisor Consultant / Advisor Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Masters Business Admin Graduate Degree Doctorate Degree Graduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal Consultant / Advisor | |
| MANNKIND CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal Sales & Marketing | |
| ARVINAS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
| Ben-Gurion University of the Negev | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer Human Resources Officer | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| University of South Carolina | College/University | Undergraduate Degree Graduate Degree | |
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of Michigan | College/University | Masters Business Admin Masters Business Admin | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Founder | |
| COYA THERAPEUTICS, INC. | Biotechnology | Director/Board Member President | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member President | |
| University of Vermont | College/University | Doctorate Degree Doctorate Degree | |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
T-Cypher Bio Ltd.
 T-Cypher Bio Ltd. Miscellaneous Commercial ServicesCommercial Services T-Cypher Bio Ltd. is a British biotechnology company. The company was founded in 2015. Thomas Lars Andresen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| St Bartholomew's Hospital Medical College | College/University | Doctorate Degree Graduate Degree | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistics
International
| United States | 39 |
| Israel | 6 |
| United Kingdom | 4 |
| Canada | 3 |
| Switzerland | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 17 |
| Finance | 4 |
| Commercial Services | 4 |
Operational
| Director/Board Member | 490 |
| Corporate Officer/Principal | 255 |
| Independent Dir/Board Member | 164 |
| Chief Tech/Sci/R&D Officer | 83 |
| Undergraduate Degree | 82 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Annalisa Jenkins | 51 |
| Stephen P. Squinto | 40 |
| Dieter Weinand | 32 |
| David Sidransky | 32 |
| David Wurzer | 31 |
| Robert Spiegel | 30 |
| Mary Gray | 27 |
| Mark Trudeau | 26 |
| Wendy Dixon | 25 |
| Leif Valdemar Johansson | 21 |
| Cristina Csimma | 21 |
| Frances K. Heller | 21 |
| Phil Ferneau | 20 |
| Todd Sone | 19 |
- Stock Market
- Insiders
- Vered Bisker-Leib
- Company connections